GlobeNewswire
-
Chiesi Global Rare Diseases Highlights Advancements in Lipodystrophy Research at ENDO 2026
18/06/2026 -
SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide
18/06/2026 -
Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
18/06/2026 -
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
18/06/2026 -
COUR Pharma Announces Closing of $50 Million Series B
18/06/2026 -
Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease
18/06/2026 -
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities
18/06/2026 -
Halberd Corporation Ships Latest NeuroSense AI Version, Advancing Voice-Based Behavioral Monitoring
18/06/2026 -
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption
18/06/2026 -
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update
18/06/2026 -
R1 Accelerates Real-Time Adjudication with New Phare OS Intelligence Engine
18/06/2026 -
23andMe Research Institute Appoints Hillary Aiken as Head of Philanthropy & Development
18/06/2026 -
Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026
18/06/2026 -
Clearmind Medicine Granted U.S. Patent for Binge Behavior Regulators
18/06/2026 -
PracticeLink Announces Spring 2026 First Practice Fund Scholarship Recipients
18/06/2026 -
Derm-Biome’s DB-006 Demonstrates Superior Efficacy in Preclinical Atopic Dermatitis Study: Reduces Itch, Inflammation, and IgE Levels, Outperforms Leading Topical Drugs
18/06/2026 -
Medicana Health Group Conducts Pre-World Cup Health Checks for the Türkiye National Football Team
18/06/2026 -
Legend Senior Living Co-CEO Matt Buchanan Named to Senior Housing News' 2026 Executives to Watch List
18/06/2026 -
New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)
18/06/2026
Pages